首页> 外文期刊>Open Heart >Exercise-based cardiac rehabilitation after heart valve surgery: cost analysis of healthcare use and sick leave
【24h】

Exercise-based cardiac rehabilitation after heart valve surgery: cost analysis of healthcare use and sick leave

机译:心脏瓣膜手术后基于运动的心脏康复:医疗保健和病假的成本分析

获取原文
       

摘要

Background Owing to a lack of evidence, patients undergoing heart valve surgery have been offered exercise-based cardiac rehabilitation (CR) since 2009 based on recommendations for patients with ischaemic heart disease in Denmark. The aim of this study was to investigate the impact of CR on the costs of healthcare use and sick leave among heart valve surgery patients over 12 months post surgery. Methods We conducted a nationwide survey on the CR participation of all patients having undergone valve surgery between 1 January 2011 and 30 June 2011 (n=667). Among the responders (n=500, 75%), the resource use categories of primary and secondary healthcare, prescription medication and sick leave were analysed for CR participants (n=277) and non-participants (n=223) over 12?months. A difference-in-difference analysis was undertaken. All estimates were presented as the means per patient (95% CI) based on non-parametric bootstrapping of SEs. Results Total costs during the 12?months following surgery were €16 065 per patient (95% CI 13?730 to 18?399) in the CR group and €15?182 (12?695 to 17?670) in the non-CR group. CR led to 5.6 (2.9 to 8.3, p0.01) more outpatient visits per patient. No statistically significant differences in other cost categories or total costs €1330 (?4427 to 7086, p=0.65) were found between the groups. Conclusions CR, as provided in Denmark, can be considered cost neutral. CR is associated with more outpatient visits, but CR participation potentially offsets more expensive outpatient visits. Further studies should investigate the benefits of CR to heart valve surgery patients as part of a formal cost-utility analysis.
机译:背景技术由于缺乏证据,自2009年以来,根据丹麦对缺血性心脏病患者的建议,对接受心脏瓣膜手术的患者进行了基于运动的心脏康复(CR)。这项研究的目的是调查CR对术后12个月内心脏瓣膜手术患者的医疗费用和病假成本的影响。方法我们对2011年1月1日至2011年6月30日之间所有接受瓣膜手术的患者的CR参与情况进行了一项全国性调查(n = 667)。在响应者(n = 500,75%)中,分析了12个月内CR参与者(n = 277)和非参与者(n = 223)的主要和辅助医疗,处方药和病假的资源使用类别。 。进行了差异分析。所有估计值均以SE的非参数自举为基础,以每位患者的均值(95%CI)表示。结果术后12个月,CR组的总费用为每位患者16065欧元(95%CI 13?730至18?399),非CR组为15 182欧元(12?695至17?670)。 CR组。 CR使每位患者的门诊次数增加了5.6(2.9至8.3,p <0.01)。两组之间没有发现其他费用类别或总费用€1330(?4427至7086,p = 0.65)的统计显着差异。结论丹麦提供的CR可以认为是成本中立的。 CR与更多的门诊就诊相关,但是CR参与可能抵消更昂贵的门诊就诊。进一步的研究应调查CR对心脏瓣膜手术患者的益处,作为正式成本效用分析的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号